In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis
UMass Chan Affiliations
Department of Clinical MicrobiologyDocument Type
Journal ArticlePublication Date
1991-07-01Keywords
Anti-Bacterial AgentsBacterial Infections
Cephalosporins
Haemophilus Infections
Haemophilus influenzae
Humans
Microbial Sensitivity Tests
Moraxella (Branhamella) catarrhalis
Respiratory Tract Infections
beta-Lactamases
Medical Microbiology